Finalist: Debra Miller

Founder & CEO
CureDuchenne

CureDuchenne, led by CEO Debra Miller, is at the forefront of research for Duchenne muscular dystrophy, which is a rare and fatal neuromuscular disease. Through a unique venture philanthropy model, CureDuchenne has funded transformative therapies and clinical trials, increasing life expectancy by 10 years. Their portfolio includes dystrophin-restoring and anti-inflammatory approaches. Miller’s dedication and leadership have driven $25 million in research investments, attracting nearly $3 billion in follow-on funding. With a pivotal gene therapy on the horizon, she remains committed to finding a cure for all affected individuals. CureDuchenne provides crucial support to families, hosts informational sessions, and founded the CureDuchenne Link Biobank. Miller’s tireless fundraising efforts, including the Getzlaf Golf Shootout and Napa in Newport, have raised millions for research and therapies. As CureDuchenne marks its 20th year, her vision and impact continue to make a difference.